Small-cap stocks are being abandoned by investors, and the damage is rippling through the wider UK economy. For decades, the smallest listed businesses on the London stock market acted as a crucial engine for growth: ambitious young companies raised money, expanded their operations and, if they succeeded, graduated into much larger enterprises. Early backers often enjoyed excellent returns along the way. That system is now breaking down. A series of regulatory changes and industry shifts has steadily diverted capital away from smaller firms and towards the largest names in the market, creating a funding drought for promising businesses and shrinking the pool of opportunities for savers seeking long-term growth. Because these changes have become deeply embedded, a reversal looks unlikely anytime soon.
The rise of passive investing and the small-cap drought
To understand why small caps have been starved of capital, it is necessary to look at how the wealth-management industry has transformed. Not long ago, stockbrokers and fund managers devoted considerable resources to researching smaller companies and allocating clients’ capital across the market, ensuring money flowed to promising businesses and share prices broadly reflected reality. That process has been dismantled. Building bespoke portfolios became increasingly expensive and administratively burdensome. Faced with rising compliance requirements and growing scrutiny over fees, many advisers stopped making investment decisions themselves. Clumsy rules from the regulator triggered this shift. To eliminate compliance risks and operational costs, advisers outsourced the entire process to mass-market model-portfolio services (MPS).
The result has been a concentration of massive wealth into a handful of firms. Four dominant discretionary managers now control the bulk of the UK MPS market: Quilter WealthSelect, Tatton Investment Management, Timeline Portfolios and AJ Bell Investments. Together they manage more than £70 billion and are growing rapidly. Crucially, the MPS marketplace relies almost entirely on passive tracking funds. Driven by regulatory pressure to keep fees low, providers invest in cheap index funds that replicate the wider market. Human judgment has been replaced by algorithms. Instead of analysing whether a business is worth buying, a passive fund allocates cash purely based on how large a company already is.
The big four allocate a combined £9 billion to the UK stock market. Yet tracing the money down to the underlying holdings reveals that almost none of it reaches smaller companies. When investment committees use passive UK equity trackers, index rules determine where the money goes. Quilter WealthSelect and Tatton Investment Management control around £50 billion between them, yet their reliance on broad market benchmarks dilutes actual small-cap exposure to around 0.3% of total assets. AJ Bell relies on trackers that systematically lop off the bottom 3% of the investable market, so its allocation to pure small caps sits at virtually nothing.
This starvation of capital has been worsened by past regulatory mistakes. New rules permanently damaged the stock market by forcing brokers to charge separately for research and trading. When active funds dominated, brokers employed armies of researchers to write detailed reports, helping fund managers decide where to invest. Brokers spent time analysing small companies to drum up interest and find buyers for shares, funding the work through trading in large companies. This research gave smaller firms visibility and kept their share prices accurate. Once the regulator banned so-called bundling, the commercial model for small-cap broking collapsed because passive tracking funds do not buy research. Today, analyst coverage for companies valued under £250 million has all but vanished. Hundreds of listed British businesses are completely ignored by the market. Institutional investors will not buy shares in a company that nobody covers, and brokers will not spend money writing about companies that the big wealth platforms are blocked from buying. Investing has become a purely automated exercise driven by index size, leaving high-quality small companies completely cut off.
The consequences extend beyond individual stocks. The UK stock market is shrinking as listed companies disappear through takeovers, private-equity bids and delistings. Low valuations lead to reduced liquidity, which in turn causes further investor withdrawals and a lack of desire for companies to go public. This destructive feedback loop – a “doom loop” – is weakening the UK’s financial ecosystem. High energy costs, subdued investment due to poor economic sentiment and the lingering effects of Brexit continue to weigh on the economy, compounding the pressure on small-cap businesses.
Finding value in a neglected market
Yet the current dysfunction creates a lucrative hunting ground for savvy investors who understand the breakdown. The key is to leave behind old-style value investing. Buying a stock simply because it looks cheap on paper is a mistake, as passive investing means that value stocks may remain cheap forever. Instead, investors must look through three specific lenses to find the stocks that can entice money from capital markets.
The first lens focuses on structural growth – high-quality businesses expanding their operations and becoming more valuable by deploying a proven commercial formula. These companies have the potential to become the mid-caps of the future. When a company grows its earnings consistently, the compounding effect eventually overwhelms the lack of market interest. Even if the valuation multiple stays depressed, the sheer scale of underlying profit expansion forces the share price higher, dragging the business out of the small-cap index to where far more investors are active.
The second lens reveals recovery plays that have hit cyclical lows. The turbulent economy of the last few years has battered corporate earnings, causing share prices to collapse and pushing formerly substantial businesses down into the small-cap sector. This is often a temporary condition driven by external cyclical factors rather than permanent structural decline. The goal is to identify businesses that have survived the worst of the downturn and have the strength to capitalise on the inevitable rebound. When the cycle turns, these companies will enjoy a dramatic recovery in earnings.
The third lens focuses on corporate activity – under-the-radar businesses where an activist investor has built a stake to force operational change, unlock shareholder value or streamline the group. This can take many forms, from cost-cutting programmes to selling off non-core assets or shrinking the share count using excess cash. Private-equity firms and larger international corporations routinely scan the UK small-cap market for high-quality assets trading at steep discounts to their private market value.
Nine stocks that fit the criteria
Several companies exemplify these opportunities. Fintel (LSE: FNTL) is a structurally growing business that is priced as if it is not. It provides critical compliance data and fintech software to thousands of British financial advisers through its dominant SimplyBiz and Defaqto brands, generating a highly predictable stream of recurring subscription income. Yet the market prices the combined entity at a steep discount to the price that similar businesses have been acquired for.
Software Circle (LSE: SFT) aims to generate structural growth via a disciplined consolidation strategy, actively buying niche software businesses in fragmented UK sectors. Though tiny today, it has all the traits necessary to deliver exceptional multi-year shareholder returns.
Amcomri Group (LSE: AMCO) operates a strict “buy, improve, build” strategy across fragmented UK engineering and manufacturing sectors. It targets high-quality industrial firms facing owner retirement, acquiring them at low single-digit multiples before driving organic margin improvements. Recent final results confirm the formula is working, with pre-tax profits significantly ahead of market expectations.
Vanquis Banking Group (LSE: VANQ) is a cyclical recovery play. Formerly a FTSE 100 stock called Provident Financial, the lender shrank into a micro-cap after major operational disasters. Management has finished cleaning up the wreckage, yet the market still prices the shares as if collapse is certain. Vanquis provides credit cards and vehicle finance to millions of sub-prime borrowers that mainstream banks ignore, and management targets mid-teens returns on tangible equity by 2027.
Focusrite (LSE: TUNE) is a clear case of a former stockmarket darling caught at a cyclical low. The audio-products group enjoyed an unprecedented sales boom during the pandemic, but as global demand normalised it wrestled with severe inventory overstocking and costly distribution headaches. Recent trading updates indicate these operational problems are finally clearing.
Marshalls (LSE: MSLH) serves as another example of a business hitting a cyclical low. The highly respected supplier to the UK building industry has been dragged down by high interest rates, inflation and policy uncertainty that have brought domestic construction to its knees. The shares historically traded at a multiple to book value, yet they currently languish at a clear discount.
Capita (LSE: CPI) is another cyclical recovery play and a fallen angel. The outsourcing giant once sat in the FTSE 100 before a collapse dragged it down to micro-cap levels. New management has aggressively cleaned up the balance sheet, selling non-core software assets to eliminate debt. The business still generates more than £2.4 billion in annual revenues yet trades at a deeply depressed valuation.
Funding Circle (LSE: FCH) is an underappreciated growth story driven by massive operational gearing. The digital platform matches small business borrowers with institutional lenders, requiring very few incremental cost rises to service new volume. Pre-tax profits recently surged from £3.4 million to £20.3 million and are on track almost to double again to £35 million this year.
SDI Group (LSE: SDI) offers a double whammy by combining structural growth with a cyclical margin recovery. The company runs a highly disciplined buy-and-build strategy, acquiring niche scientific-instrument businesses specialising in optics and photonics. A recent downturn in core scientific end markets has depressed earnings, but as laboratory budgets normalise and margins recover, investors could capture both compounding growth and an explosive rebound.
Specialist funds for those who prefer to delegate
Picking individual micro-cap stocks requires patience and knowledge, and is not for everyone. For investors who prefer to delegate the task, two specific investment trusts have proved their ability to navigate these markets. Rockwood Strategic (LSE: RKW) is managed by Richard Staveley, who has more than 25 years of experience. He runs a concentrated portfolio of undervalued businesses and engages directly with boards to unlock value. Onward Opportunities (LSE: ONWD), launched by lead manager Laurence Hulse in March 2023, provides exposure to some of the smallest companies listed in the UK, operating in the most illiquid territory. Its execution has been outstanding since inception.
For those selecting individual stocks today, three stand out. Focusrite is a cyclical recovery play that has finally cleared post-pandemic hurdles and positioned its manufacturing operations for a strong earnings recovery. Vanquis Banking Group remains absurdly mispriced, trading at a steep discount to its underlying net asset value while the market ignores its mid-teens profitability targets. Software Circle provides an underappreciated growth story with a disciplined, decentralised model for integrating niche acquisitions. Investors who back these stocks will gain direct exposure to tangibly improving businesses. For those who prefer to delegate, Rockwood Strategic is the ideal vehicle, offering instant diversification across a concentrated basket of deeply undervalued turnaround plays.
